Menopause & Midlife Health Expert Series 2027

A specialist-led program designed to strengthen real-world clinical decision-making across the most common and complex menopause and midlife presentations in primary care.

January 12 – March 16, 2027

Tuesdays | 7:00 PM to 9:00 PM ET | Live and on-demand

Super early bird: $199 until October 31 | Early bird: $249 until November 30 | Regular: $349

Prices shown in CAD. USD pricing available at checkout.

Trusted by clinicians across Canada 🇨🇦 and the United States 🇺🇸 • Earn 20 ANCC contact hours

NP Circle is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Why attend?

Menopause and midlife concerns often overlap with other common primary care presentations. Patients may present with changes in bleeding, migraine, mood, sleep, sexual health, weight, or other concerns, and deciding what to assess, investigate, treat, or refer is not always straightforward.

The 2027 Menopause & Midlife Health Expert Series is designed to help NPs and other primary care clinicians navigate menopause and midlife care with greater confidence. Across 10 specialist-led sessions, you will learn practical approaches for perimenopause, early menopause, primary ovarian insufficiency, abnormal uterine bleeding, hormone therapy, mood, sleep and cognitive changes, migraine, sexual and vulvovaginal health, weight management and cardiometabolic risk, bone health, cancer survivorship, and complex menopause care.

Each session is grounded in real-world practice and includes current evidence, practical prescribing guidance, case discussions, and live Q&A. Join live or watch the recordings on demand when it works for you.

How does it work?

Register once for access to all 10 accredited online sessions.

Each weekly session runs for 2 hours:

  • Specialist-led teaching (75 minutes): Explore a high-impact clinical topic through practical guidance, current evidence, and case-based discussion.

  • Live Q&A (45 minutes): Ask the specialist your questions and work through challenging clinical scenarios.

All sessions are recorded and uploaded to the NP Circle platform. Attend live, watch on-demand, or use a combination of both.

Complete the series to earn 20 ANCC contact hours. A certificate of completion is available to learners who meet the activity requirements.

Who should attend?

This series is designed for nurse practitioners working in primary care, women’s health, and specialized settings who want to strengthen their approach to menopause and midlife care or stay current as the evidence continues to evolve.

Family physicians, physician assistants, registered nurses, midwives, pharmacists, and other healthcare professionals involved in menopause and midlife care are also welcome.

The content assumes a foundational understanding of primary care and is suitable for both early-career and experienced clinicians.

Agenda

  • Perimenopause, Early Menopause, and POI: Diagnosis and Management

    JANUARY 12, 2027
    7:00 PM to 9:00 PM ET

    Learning objectives

    1. Differentiate perimenopause, early menopause, and primary ovarian insufficiency from common overlapping conditions.

    2. Determine when clinical assessment is sufficient and when targeted testing or further investigation is indicated.

    3. Develop an individualized treatment and follow-up plan addressing symptoms, reproductive needs, and long-term health.

    Speaker

    To be announced.

  • Menopausal Hormone Therapy: Practical Prescribing and Troubleshooting

    JANUARY 19, 2027
    7:00 PM to 9:00 PM ET

    Learning objectives

    1. Select estrogen and progestogen regimens based on symptoms, uterine status, clinical risk, and patient preferences.

    2. Apply current evidence when counselling patients about benefits, risks, contraindications, treatment duration, and available alternatives.

    3. Troubleshoot persistent symptoms, adverse effects, unscheduled bleeding, and requests for compounded hormone therapy.

    Speaker

    To be announced.

  • Bleeding in Midlife: Evaluation and Management

    JANUARY 26, 2027
    7:00 PM to 9:00 PM ET

    Learning objectives

    1. Differentiate expected perimenopausal bleeding changes from patterns requiring further evaluation.

    2. Select appropriate laboratory testing, imaging, and endometrial assessment based on bleeding patterns and clinical risk.

    3. Manage perimenopausal, hormone therapy-related, and postmenopausal bleeding and determine when referral is indicated.

    Speaker

    To be announced.

  • Mood, Sleep, and Cognitive Changes in Midlife

    FEBRUARY 2, 2027
    7:00 PM to 9:00 PM ET

    Learning objectives

    1. Differentiate menopause-associated symptoms from psychiatric disorders, primary sleep disorders, medication effects, and medical or cognitive conditions.

    2. Select behavioural, pharmacological, and menopause-specific treatments based on the predominant symptoms and health history.

    3. Recognize psychiatric, cognitive, and sleep-related red flags requiring urgent assessment, further investigation, or referral.

    Speaker

    To be announced.

  • Migraine Across the Menopause Transition: Hormones, Treatment, and Risk

    FEBRUARY 9, 2027
    7:00 PM to 9:00 PM ET

    Learning objectives

    1. Assess changes in migraine across the menopause transition and identify headache features requiring further investigation.

    2. Individualize hormone therapy and contraception based on migraine type, symptom patterns, and vascular risk.

    3. Select acute, preventive, hormonal, and nonhormonal treatment strategies and determine when referral is needed.

    Speaker

    To be announced.

  • Sexual Health in Midlife: Desire, Pain, and Testosterone Therapy

    FEBRUARY 16, 2027
    7:00 PM to 9:00 PM ET

    Learning objectives

    1. Assess low desire, arousal and orgasm concerns, and sexual pain using a biopsychosocial approach.

    2. Select pharmacological, nonpharmacological, pelvic floor, and interdisciplinary treatment strategies.

    3. Identify appropriate candidates for testosterone therapy and apply evidence-based prescribing and monitoring practices.

    Speaker

    To be announced.

  • Vulvovaginal Health: GSM, Dermatoses, and Lesions

    FEBRUARY 23, 2027
    7:00 PM to 9:00 PM ET

    Learning objectives

    1. Differentiate genitourinary syndrome of menopause, infection, vulvar dermatoses, vulvodynia, and concerning lesions using history and examination findings across skin tones.

    2. Select hormonal and nonhormonal treatments for common genitourinary, urinary, and vulvar presentations.

    3. Identify findings requiring biopsy, urgent assessment, or specialist referral.

    Speaker

    To be announced.

  • Weight Management and Cardiometabolic Health in Midlife

    MARCH 2, 2027
    7:00 PM to 9:00 PM ET

    Learning objectives

    1. Assess contributors to weight change, obesity, and cardiometabolic risk across the menopause transition.

    2. Compare nutritional, physical activity, behavioural, and pharmacological treatments based on comorbidities and patient goals.

    3. Integrate weight management and menopause treatment with the prevention and management of diabetes, hypertension, dyslipidemia, and cardiovascular disease.

    Speaker

    To be announced.

  • Bone Health in Midlife: Osteoporosis and Fracture Prevention

    MARCH 9, 2027
    7:00 PM to 9:00 PM ET

    Learning objectives

    1. Assess fracture risk and determine when bone density testing and evaluation for secondary causes are indicated.

    2. Select exercise, nutritional, and pharmacological interventions based on fracture risk, comorbidities, and previous treatment.

    3. Plan treatment monitoring, duration, sequencing, and discontinuation to support long-term bone and muscle health.

    Speaker

    To be announced.

  • Complex Menopause Care: Cancer, Medical Risk, and Clinical Decisions

    MARCH 16, 2027
    7:00 PM to 9:00 PM ET

    Learning objectives

    1. Evaluate hormonal and nonhormonal treatment options for patients with a history of cancer or complex medical conditions.

    2. Apply current evidence to menopause treatment decisions involving cardiovascular, thromboembolic, hepatic, and other clinical risks.

    3. Develop individualized treatment, monitoring, and referral plans for complex menopause cases.

    Speaker

    To be announced.

Sponsors to be announced soon.

 FAQs

Testimonials

Learn with clinicians across North America

Super early bird: $199 until October 31 | Early bird: $249 until November 30 | Regular: $349

Prices shown in CAD. USD pricing available at checkout.